Skip to Content

Join the 'Afstyla' group to help and get support from people like you.

Afstyla News

FDA Approves Afstyla (Antihemophilic Factor (Recombinant), Single Chain) for Hemophilia A

Posted 8 Jun 2016 by

KING OF PRUSSIA, Pa. — 26 May 2016 – CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved Afstyla [Antihemophilic Factor (Recombinant), Single Chain], its novel long-lasting recombinant factor VIII single-chain therapy for adults and children with hemophilia A. Afstyla is the first and only single-chain product for hemophilia A that is specifically designed f ...

Ask a Question

Further Information

Related Condition Support Groups

Hemophilia A

Afstyla Patient Information at